Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | NOD1 | Q9Y239 | 10/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.45 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3776147 | 1.00 | KMT2A (0.69) | KMT2ANOD1POLBL3MBTL1MEN1 | |
| SCHEMBL27754272 | 1.00 | KMT2A (0.69) | KMT2ANOD1POLBL3MBTL1MEN1 | |
| SCHEMBL3773778 | 1.00 | KMT2A (0.69) | KMT2ANOD1POLBL3MBTL1MEN1 | |
| SCHEMBL27754307 | 1.00 | KMT2A (0.69) | KMT2ANOD1POLBL3MBTL1MEN1 | |
| SCHEMBL28329549 | 0.99 | KMT2A (0.68) | KMT2ANOD1POLBL3MBTL1MEN1 | |
| SCHEMBL3773081 | 0.90 | NOD1 (0.67) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL3773080 | 0.90 | NOD1 (0.67) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL3773070 | 0.90 | NOD1 (0.67) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL28120619 | 0.90 | NOD1 (0.63) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL5705135 | 0.90 | NOD1 (0.56) | KMT2ANOD1POLBMEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8618171-B2 | Encapsulated oil-in-water type emulsion composition | AJINOMOTO CO., INC. (JP) | 2013-12-31 | — | — | US | disclosed |
| EP-1980237-B1 | GELLING AGENT | AJINOMOTO KK (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-7850955-B2 | contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants | AJINOMOTO CO., INC. (JP) | 2010-12-14 | — | — | US | disclosed |
| CN-101365415-A | Gelling agent | AJINOMOTO KK (JP) | 2009-02-11 | — | — | CN | disclosed |
| US-20080311164-A1 | GELLING AGENT | AJINOMOTO CO. INC (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1980237-A1 | GELLING AGENT | Ajinomoto Co., Inc. (JP) | 2008-10-15 | — | — | EP | disclosed |
| US-20070265347-A1 | ENCAPSULATED OIL-IN-WATER TYPE EMULSION COMPOSITION | AJINOMOTO CO. INC (JP) | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265347-A1 | ENCAPSULATED OIL-IN-WATER TYPE EMULSION COMPOSITION | AGPAT2, GPR18, AGPAT5 | KMT2A 1159/4885NOD1 3457/4885POLB 872/4885 |
| US-20080311164-A1 | GELLING AGENT | CUTA, NAAA, ASIC1 | KMT2A 616/4885NOD1 3559/4885POLB 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.